Invitrogen™ Human NAT11 Synthetic Peptide

Catalog No.	Quantity
PEP0996	50 μg

Catalog No. PEP0996 Supplier Invitrogen™ Supplier No. PEP0996

Description

Synthetic Peptide

NAT11 Synthetic Peptide, PEP-0996, from Invitrogen.

N-terminal acetylation is one of the most common protein modifications in eukaryotes, occurring on approximately 57% and 84% on yeast and human proteins respectively. There are several N-terminal acetylating enzyme complexes (NatA - NatE). Unlike the other complexes, NatD is composed of a single protein, NAT11, and has recently been described to acetylate the Serine N-termini of histones H2A and H4 in yeast. The role these modifications play is unknown; yeast that do not express NAT11 grow at normal rates and have no observable phenotypes. The role of the human homolog is likewise unknown.

Specifications

• Gene ID (Entrez): 79829
• Species: Human
• Purification Method: purified
• Accession Number: Q86UY6
• Common Name: Human NAT11
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: NAA40
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov